From the revised earnings beat MRQ with recent upward estimate revisions screen. The weekly chart is approaching overbought but I needed a replacement for last week's pick which now has a red elder bar. Here is the weekly chart for CC stockcharts.com/h-sc/ui?s=CC&p=W&b=5&g=0&id=p55919208224
Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, acquiring, developing and commercializing proprietary therapeutics that target both cancer stem cells, or CSCs, and tumor bulk.
architecto25 was aboard a rocket this week and wins by almost forty lengths. kadee72 had a good gain in second and clarkrl2 used a late week rally to take third. Those were the only players beating the benchmark.